Zheng Guo

5.9k total citations
210 papers, 4.2k citations indexed

About

Zheng Guo is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Zheng Guo has authored 210 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 146 papers in Molecular Biology, 57 papers in Cancer Research and 36 papers in Oncology. Recurrent topics in Zheng Guo's work include Bioinformatics and Genomic Networks (66 papers), Gene expression and cancer classification (65 papers) and Cancer Genomics and Diagnostics (25 papers). Zheng Guo is often cited by papers focused on Bioinformatics and Genomic Networks (66 papers), Gene expression and cancer classification (65 papers) and Cancer Genomics and Diagnostics (25 papers). Zheng Guo collaborates with scholars based in China, United States and Canada. Zheng Guo's co-authors include Yunyan Gu, Wenyuan Zhao, Xia Li, Lishuang Qi, Guini Hong, Qingzhou Guan, Lu Ao, Chenguang Wang, Hong‐Dong Li and Chen Yao and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Bioinformatics.

In The Last Decade

Zheng Guo

202 papers receiving 4.2k citations

Peers

Countries citing papers authored by Zheng Guo

Since Specialization

Citations

This map shows the geographic impact of Zheng Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zheng Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zheng Guo more than expected).

Fields of papers citing papers by Zheng Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zheng Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zheng Guo. The network helps show where Zheng Guo may publish in the future.

Co-authorship network of co-authors of Zheng Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Zheng Guo. A scholar is included among the top collaborators of Zheng Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zheng Guo. Zheng Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genetic expression in cancer research: Challenges and complexity 2024 ·Gene Reports ·Hengrui Liu, Zheng Guo, Panpan Wang	38
2	658P Furmonertinib 160mg as first-line treatment for advanced non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) exon 21 L858R mutation 2024 ·Annals of Oncology ·Meiqi Shi, Bo Shen, Chenwei Wang, Lixin Zhang, Yingying Zhu, Lingling Wang, Zheng Guo	0
3	651P Phase I study of XNW27011, a novel claudin 18.2 ADC, in patients with locally advanced and/or metastatic solid tumors 2024 ·Annals of Oncology ·Jingwei Yu, Yan Sun, Tingting Liu, (unknown), Zheng Guo, Xiao Liang, Feng Ning, Minghui Zhang, Yi Zhang, Na Zhang, Lingling Wang, Hongyun Zhao, Yongxian Hu, (unknown), Yanxia Zhao, Yehong Wang, Qing Shi, (unknown)	3
4	Toxic effects of perfluorocaproic acid (PFHxA) on crucian carp (Carassius auratus) and the response of the intestinal microbial community 2023 ·Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology ·Xue Jiao, Zheng Guo, (unknown), Long Wang, (unknown), Yuan Yang, Qian Ai-dong, Yuehong Li	5
5	Multiphase and multiparameter MRI-based radiomics for prediction of tumor response to neoadjuvant therapy in locally advanced rectal cancer 2023 ·Radiation Oncology ·Hongyan Huang, Lujun Han, (unknown), Yanyu Zhang, (unknown), Shengli Chen, Xiaoshan Lin, (unknown), Zheng Guo, Yingwei Qiu	9
6	Standard radiotherapy for patients with nasopharyngeal carcinoma results in progressive tract-specific brain white matter alterations: A one-year follow-up via diffusion tensor imaging 2021 ·Radiotherapy and Oncology ·Yingwei Qiu, Zheng Guo, Xiaoshan Lin, Jing Li, Zhipeng Li, Lujun Han, (unknown), Xiaofei Lv	13
7	Identification of Genes Universally Differentially Expressed in Gastric Cancer 2021 ·BioMed Research International ·Yidan Shi, Lishuang Qi, (unknown), Jiahui Zhang, Qingzhou Guan, Jun He, Meifeng Li, Zheng Guo, Haidan Yan, Ping Li	7
8	A Qualitative Transcriptional Signature for Predicting Prognosis and Response to Bevacizumab in Metastatic Colorectal Cancer 2020 ·Molecular Cancer Therapeutics ·Jing Yang, Kai Song, Wenbing Guo, Hailong Zheng, (unknown), Tianyi You, Kai Wang, Lishuang Qi, Wenyuan Zhao, Zheng Guo	5
9	Aberrant inter-hemispheric coordination characterizes the progression of minimal hepatic encephalopathy in patients with HBV-related cirrhosis 2020 ·NeuroImage Clinical ·Min Ye, Zheng Guo, (unknown), Xiaoshan Lin, Jing Li, Guihua Jiang, (unknown), Yingwei Qiu, Lujun Han, Xiaofei Lv	14
10	A qualitative transcriptional signature for the histological reclassification of lung squamous cell carcinomas and adenocarcinomas 2019 ·BMC Genomics ·Xin Li, (unknown), (unknown), Wenbin Jiang, Yixin Liu, Sainan Zhang, Zheyang Zhang, Zixin Wei, Fei He, Zheng Guo, Lishuang Qi	8
11	Network-level dysconnectivity in patients with nasopharyngeal carcinoma (NPC) early post-radiotherapy: longitudinal resting state fMRI study 2017 ·Brain Imaging and Behavior ·Yingwei Qiu, Zheng Guo, Lujun Han, Yadi Yang, Jing Li, Shiliang Liu, Xiaofei Lv	30
12	The significance of copy number variation in multiple osteosarcoma's malignance grade, drug resistance and classification 2015 ·Zhonghua guke zazhi ·Haoqiang Zhang, Zhen Wang, (unknown), Mengjie Liu, Peng Gao, Xin Xiao, Lei Geng, Yulin Yuan, Guojing Chen, (unknown), Jun Fu, (unknown), Zheng Guo, Jing Li, Xiangdong Li	2
13	Deciphering global signal features of high-throughput array data from cancers 2014 ·Molecular BioSystems ·Deng Wu, Juanjuan Kang, Yan Huang, Xiang Li, Xiansong Wang, Dan Huang, Yuting Wang, Bin Li, Dapeng Hao, Qi Gu, Nelson L.S. Tang, Kongning Li, Zheng Guo, (unknown), (unknown), Jianzhen Xu, Dong Wang	7
14	Network analysis of genomic alteration profiles reveals co-altered functional modules and driver genes for glioblastoma 2013 ·Molecular BioSystems ·Yunyan Gu, Hongwei Wang, Qin Yao, Yujing Zhang, Wenyuan Zhao, Lishuang Qi, Yuannv Zhang, Chenguang Wang, Zheng Guo	15
15	Extensive up-regulation of gene expression in cancer: the normalised use of microarray data 2012 ·Molecular BioSystems ·Dong Wang, Lixin Cheng, Yuannv Zhang, Ruihong Wu, Mingyue Wang, Yunyan Gu, Wenyuan Zhao, Pengfei Li, Bin Li, Yujing Zhang, Hongwei Wang, Yan Huang, Chenguang Wang, Zheng Guo	24
16	Identifying Disease-Associated Functions Based on Weak Signals of Differential Expressions of Genes 2012 ·Zheng Guo	1
17	Evaluating the Consistency of Differential Expression of MicroRNA Detected in Human Cancers 2011 ·Molecular Cancer Therapeutics ·Xue Gong, Ruihong Wu, Hongwei Wang, Xinwu Guo, Dong Wang, Yunyan Gu, Yuannv Zhang, Wenyuan Zhao, Lixin Cheng, Chenguang Wang, Zheng Guo	10
18	Finding co-mutated genes and candidate cancer genes in cancer genomes by stratified false discovery rate control 2011 ·Molecular BioSystems ·Jing Wang, Yang Zhang, Xiaopei Shen, Jing Zhu, Lin Zhang, Jinfeng Zou, Zheng Guo	8
19	Systematic Interpretation of Comutated Genes in Large-Scale Cancer Mutation Profiles 2010 ·Molecular Cancer Therapeutics ·Yunyan Gu, Da Yang, Jinfeng Zou, Wencai Ma, Ruihong Wu, Wenyuan Zhao, Yuannv Zhang, (unknown), Xue Gong, Min Zhang, Jing Zhu, Zheng Guo	15
20	Proteomics of epilepsy induced by focal disorder of cortical development 2010 ·Chinese Journal of Neuromedicine ·Yanjun Huang, Zheng Guo, Xiaopeng Lu, (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact